Shell Asset Management Co. raised its position in shares of Orthofix Medical Inc. (NASDAQ:OFIX – Get Rating) by 28.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,654 shares of the medical device company’s stock after buying an additional 2,333 shares during the quarter. Shell Asset Management Co.’s holdings in Orthofix Medical were worth $348,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC purchased a new position in shares of Orthofix Medical in the 4th quarter worth approximately $2,673,000. Yousif Capital Management LLC purchased a new position in shares of Orthofix Medical in the 4th quarter worth approximately $548,000. Paradigm Capital Management Inc. NY purchased a new position in shares of Orthofix Medical in the 4th quarter worth approximately $1,001,000. Factorial Partners LLC boosted its holdings in shares of Orthofix Medical by 14.5% in the 4th quarter. Factorial Partners LLC now owns 31,500 shares of the medical device company’s stock worth $979,000 after purchasing an additional 4,000 shares during the period. Finally, Heartland Advisors Inc. boosted its holdings in shares of Orthofix Medical by 53.6% in the 4th quarter. Heartland Advisors Inc. now owns 357,800 shares of the medical device company’s stock worth $11,124,000 after purchasing an additional 124,800 shares during the period. Hedge funds and other institutional investors own 97.93% of the company’s stock.
Orthofix Medical Price Performance
Shares of OFIX stock opened at $22.77 on Friday. Orthofix Medical Inc. has a 52-week low of $22.66 and a 52-week high of $43.30. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.88 and a current ratio of 2.89. The firm has a market capitalization of $453.40 million, a P/E ratio of -12.24 and a beta of 1.01. The stock has a 50 day moving average price of $25.12 and a 200 day moving average price of $29.18.
Wall Street Analyst Weigh In
Separately, StockNews.com cut Orthofix Medical from a “buy” rating to a “hold” rating in a report on Tuesday, May 10th.
Orthofix Medical Company Profile
Orthofix Medical Inc operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures.
- Get a free copy of the StockNews.com research report on Orthofix Medical (OFIX)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.